医学
阿司匹林
心力衰竭
心室辅助装置
内科学
心脏病学
重症监护医学
作者
Mandeep R. Mehra,Ivan Netuka,Nir Uriel,Jason N. Katz,Francis D. Pagani,Ulrich P. Jorde,Finn Gustafsson,Jean M. Connors,Peter Ivák,Jennifer Cowger,John Ransom,Aditya Bansal,Koji Takeda,Richa Agarwal,Mirnela Byku,Michael M. Givertz,Abbas Bitar,Shelley Hall,Daniel Zimpfer,J. David Vega
出处
期刊:JAMA
[American Medical Association]
日期:2023-11-11
卷期号:330 (22): 2171-2171
被引量:75
标识
DOI:10.1001/jama.2023.23204
摘要
Left ventricular assist devices (LVADs) enhance quality and duration of life in advanced heart failure. The burden of nonsurgical bleeding events is a leading morbidity. Aspirin as an antiplatelet agent is mandated along with vitamin K antagonists (VKAs) with continuous-flow LVADs without conclusive evidence of efficacy and safety.
科研通智能强力驱动
Strongly Powered by AbleSci AI